360 NEWS360 NEWS
Home / Business

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Published
Original News Source CNBC — Business
Source Website www.cnbc.com ↗
Content & Media Rights CNBC — Business
Editorial Publisher 360 NEWS (Independent Media)
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Photo / Source: CNBC — Business
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].